Evidence map›Paper›PMID 37064226›Full record

ArticleFrontiers in bioengineering and biotechnology2023

Multiscale design of cell-free biologically active architectural structures.

G Ho, V Kubušová, C Irabien, V Li, A Weinstein, Sh Chawla, D Yeung, A Mershin, K Zolotovsky, L Mogas-Soldevila

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Designing with Printed Responsive Biomaterials: A Review.3D printing and additive manufacturing · 2025
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

G HoDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA, United States.
V KubušováDepartment of Graduate Architecture, DumoLab Research, Stuart Weitzman School of Design, University of Pennsylvania, Philadelphia, PA, United States.
C IrabienDepartment of Graduate Architecture, DumoLab Research, Stuart Weitzman School of Design, University of Pennsylvania, Philadelphia, PA, United States.
V LiDepartment of Graduate Architecture, DumoLab Research, Stuart Weitzman School of Design, University of Pennsylvania, Philadelphia, PA, United States.
A WeinsteinDepartment of Graduate Architecture, DumoLab Research, Stuart Weitzman School of Design, University of Pennsylvania, Philadelphia, PA, United States.
Sh ChawlaDepartment of Graduate Architecture, DumoLab Research, Stuart Weitzman School of Design, University of Pennsylvania, Philadelphia, PA, United States.
D YeungDepartment of Graduate Architecture, DumoLab Research, Stuart Weitzman School of Design, University of Pennsylvania, Philadelphia, PA, United States.
A MershinLabel Free Research Group, Center for Bits and Atoms, Massachusetts Institute of Technology, Cambridge, MA, United States.
K ZolotovskySpatial Dynamics Program, Division of Experimental and Foundational Studies, Rhode Island School of Design, Providence, RI, United States.
L Mogas-SoldevilaDepartment of Graduate Architecture, DumoLab Research, Stuart Weitzman School of Design, University of Pennsylvania, Philadelphia, PA, United States.
University of Pennsylvania · USMassachusetts Institute of Technology · USProvidence College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell-free protein expression systems are here combined with 3D-printed structures to study the challenges and opportunities as biofabrication enters the spaces of architecture and design. Harnessing large-scale additive manufacturing of biological materials, we examined the addition of cell-free protein expression systems ("TXTL" i.e., biological transcription-translation machinery without the use of living cells) to printed structures. This allowed us to consider programmable, living-like, responsive systems for product design and indoor architectural applications. This emergent, pluripotent technology offers exciting potential in support of health, resource optimization, and reduction of energy use in the built environment, setting a new path to interactivity with mechanical, optical, and (bio) chemical properties throughout structures. We propose a roadmap towards creating healthier, functional and more durable systems by deploying a multiscale platform containing biologically-active components encapsulated within biopolymer lattices operating at three design scales: (i) supporting cell-free protein expression in a biopolymer matrix (microscale), (ii) varying material properties of porosity and strength within two-dimensional lattices to support biological and structural functions (mesoscale), and (iii) obtaining folded indoor surfaces that are structurally sound at the meter scale and biologically active (we label that regime macroscale). We embedded commercially available cell-free protein expression systems within silk fibroin and sodium alginate biopolymer matrices and used green fluorescent protein as the reporter to confirm their compatibility. We demonstrate mechanical attachment of freeze-dried bioactive pellets into printed foldable fibrous biopolymer lattices showing the first steps towards modular multiscale fabrication of large structures with biologically active zones. Our results discuss challenges to experimental setup affecting expression levels and show the potential of robust cell-free protein-expressing biosites within custom-printed structures at scales relevant to everyday consumer products and human habitats.

Indexed as

additive manufacturingbiodesignbiofabricationbiointeractive architecturecell-free systemsinteractive biomaterialsmaterial-driven designprogrammable matter

Identifiers

PMID37064226
PMCPMC10100494
OpenAlexW4361214070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.